Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 5086 AL 5100

From Pathology to Materials Science and Engineering: Harnessing the Amyloid State for Biotechnological Applications

Fallot LB, Natarajan C, Anderson CA, Nagelli EA, Burpo FJ, Limbocker R.

ACS Appl Mater Interfaces. 2025 Nov 19;17(46):62839-62859. doi: 10.1021/acsami.5c11847. Epub 2025 Nov 10.

Research on the Application of Mesenchymal Stem Cells for Addressing Mitochondrial Damage in Neurodegenerative Diseases

Zhang L, Ge Y, Wu J, Wang M, Huang N, Luo Y.

Cell Mol Neurobiol. 2025 Nov 10;45(1):101. doi: 10.1007/s10571-025-01624-3.

VReeze: an open-source virtual reality for the examination of freezing of gait in Parkinson's disease - a study design of a crossover repeated measures study for validation

Siragy T, Russo Y, Hirschbichler S, Nantel J, Wegscheider P, Schweiger H, Simonlehner M, Kisiel M, Horsak B.

BMJ Open. 2025 Nov 9;15(11):e106489. doi: 10.1136/bmjopen-2025-106489.

CHI3L1: An Emerging Player in Neuroinflammation and Neurodegeneration

Mushtaq U, Seh BA, Khanday FA, Ahmad M.

Mol Neurobiol. 2025 Nov 10;63(1):23. doi: 10.1007/s12035-025-05354-x.

A Unique Case of Metastatic Paraganglioma in a Patient With Parkinson Disease

Aye ST, Oo TD, Lwin NA.

JCEM Case Rep. 2025 Nov 7;3(12):luaf262. doi: 10.1210/jcemcr/luaf262. eCollection 2025 Dec.

Corrigendum to "Leveraging ANFIS with Adam and PSO optimizers for Parkinson's disease" [Heliyon Volume 10, Issue 9, May 15, 2024, Article e30241]

Pasha A, Ahmed ST, Painam RK, Mathivanan SK, P K, Mallik S, Qin H.

Heliyon. 2025 Jun 14;11(12):e43492. doi: 10.1016/j.heliyon.2025.e43492. eCollection 2025 Jul.

Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson's disease: the ADepT-PD RCT pilot

Schrag A, Carroll C, Lewis G, Serfaty M, Duncan G, Molloy S, Whipps J, McLennan B, Weng JYJ, Hunter RM, Clarke CS, Freemantle N, Embleton-Thirsk A.

Health Technol Assess. 2025 Nov;29(57):1-78. doi: 10.3310/HFDO7575.

Deep transcranial magnetic stimulation in progressive supranuclear palsy: a randomized double-blind, cross-over study

Radicati FG, Vacca L, Casali M, Tremigliozzi I, Alborghetti M, Lombardi M, Rossini PM, Stocchi F.

Neurol Sci. 2025 Dec;46(12):6923-6931. doi: 10.1007/s10072-025-08549-1. Epub 2025 Nov 12.

The Importance of Medication Reconciliation in a Patient with Parkinson's Disease

Wright SS, Wright C.

Sr Care Pharm. 2025 Nov 1;40(11):443-449. doi: 10.4140/TCP.n.2025.443.

Dopamine Dysregulation Syndrome in Parkinson's Disease

Lee AJ, Poon LH.

Sr Care Pharm. 2025 Nov 1;40(11):450-456. doi: 10.4140/TCP.n.2025.450.

Approaches to sensory-motor symptoms in neurological diseases

Özden F, Özkeskin M, Baser M.

Somatosens Mot Res. 2025 Nov 11:1-13. doi: 10.1080/08990220.2025.2585799. Online ahead of print.

Editorial: Integrating technology into advanced Parkinson's disease management: from screening and evaluation to treatment and prevention

Phokaewvarangkul O, Youn J, Paramanandam V, Picillo M.

Front Neurol. 2025 Oct 27;16:1712760. doi: 10.3389/fneur.2025.1712760. eCollection 2025.

Diverse RNAs in human umbilical cord-derived exosomes and their therapeutic potential

Khezrian A, Sobhi Amjad Z, Khaghani Boroujeni A, Shojaeian A.

RNA Biol. 2025 Dec;22(1):1-14. doi: 10.1080/15476286.2025.2589583. Epub 2025 Nov 12.

Pharmacogenetics in advanced Parkinson's disease

Kulisevsky J, García-Ruíz P, Outeiro TF, Gurevich T, Klivènyi P, Van Laar T, Milanov I, Pirker W, Popescu BO, Toft M, Szász JA.

J Neural Transm (Vienna). 2025 Nov;132(11):1719-1726. doi: 10.1007/s00702-025-03057-0. Epub 2025 Nov 12.

Exploring the impact of metformin on the central nervous system and neurotransmission: A systematic review

Maciejczyk A, Blecharz-Klin K.

Biomed Pharmacother. 2025 Dec;193:118743. doi: 10.1016/j.biopha.2025.118743. Epub 2025 Nov 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias